Zurcher Kantonalbank Zurich Cantonalbank Reduces Stock Position in Equifax Inc. (NYSE:EFX)

Zurcher Kantonalbank Zurich Cantonalbank lowered its stake in shares of Equifax Inc. (NYSE:EFX - Free Report) by 47.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 20,642 shares of the credit services provider's stock after selling 18,776 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Equifax were worth $5,105,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Tobam boosted its stake in shares of Equifax by 37.2% during the 4th quarter. Tobam now owns 568 shares of the credit services provider's stock valued at $140,000 after purchasing an additional 154 shares in the last quarter. Turtle Creek Wealth Advisors LLC bought a new stake in shares of Equifax during the 4th quarter valued at about $41,000. Parnassus Investments LLC boosted its stake in shares of Equifax by 38.8% during the 3rd quarter. Parnassus Investments LLC now owns 113,315 shares of the credit services provider's stock valued at $20,757,000 after purchasing an additional 31,686 shares in the last quarter. Premier Path Wealth Partners LLC bought a new stake in shares of Equifax during the 4th quarter valued at about $1,240,000. Finally, Tower Research Capital LLC TRC boosted its stake in shares of Equifax by 243.0% during the 3rd quarter. Tower Research Capital LLC TRC now owns 11,181 shares of the credit services provider's stock valued at $2,048,000 after purchasing an additional 7,921 shares in the last quarter. Hedge funds and other institutional investors own 96.20% of the company's stock.


Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. Oppenheimer cut their target price on shares of Equifax from $291.00 to $272.00 and set an "outperform" rating on the stock in a research note on Friday. Truist Financial boosted their price objective on shares of Equifax from $270.00 to $285.00 and gave the stock a "buy" rating in a research note on Friday, February 9th. Robert W. Baird dropped their price objective on shares of Equifax from $275.00 to $260.00 and set an "outperform" rating on the stock in a research note on Friday. Redburn Atlantic lowered shares of Equifax from a "buy" rating to a "neutral" rating and set a $272.00 price objective on the stock. in a research note on Thursday, January 11th. Finally, Stifel Nicolaus boosted their price objective on shares of Equifax from $208.00 to $289.00 and gave the stock a "buy" rating in a research note on Tuesday, January 9th. Four analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $270.19.

Read Our Latest Stock Analysis on EFX

Equifax Stock Up 1.3 %

Shares of EFX traded up $2.73 during mid-day trading on Monday, hitting $218.93. 2,070,718 shares of the company's stock were exchanged, compared to its average volume of 858,003. The company has a market cap of $27.20 billion, a price-to-earnings ratio of 48.76, a P/E/G ratio of 1.74 and a beta of 1.51. Equifax Inc. has a fifty-two week low of $159.95 and a fifty-two week high of $275.10. The company has a debt-to-equity ratio of 1.04, a quick ratio of 0.67 and a current ratio of 0.73. The stock's 50-day moving average is $257.79 and its 200-day moving average is $231.94.

Equifax (NYSE:EFX - Get Free Report) last issued its earnings results on Thursday, April 18th. The credit services provider reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.44 by $0.06. The firm had revenue of $1.39 billion for the quarter, compared to analysts' expectations of $1.40 billion. Equifax had a net margin of 10.42% and a return on equity of 19.08%. The firm's revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.43 earnings per share. On average, sell-side analysts anticipate that Equifax Inc. will post 7.38 earnings per share for the current fiscal year.

Equifax Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, February 23rd were issued a $0.39 dividend. The ex-dividend date was Thursday, February 22nd. This represents a $1.56 annualized dividend and a yield of 0.71%. Equifax's dividend payout ratio (DPR) is 34.74%.

About Equifax

(Free Report)

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

See Also

Institutional Ownership by Quarter for Equifax (NYSE:EFX)

→ The Gold Grab of the Century (From Colonial Metals) (Ad)

Should you invest $1,000 in Equifax right now?

Before you consider Equifax, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.

While Equifax currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: